SCHEMBL3810000

SCHEMBL3810000

Cc1cc(C)n(C(=O)NCCCCCCNC(=O)n2nc(C)cc2C)n1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ASAH1 Q13510 1/20 0.60
ALDH1A1 P00352 5/20 0.58
KMT2A Q03164 3/20 0.58
MEN1 O00255 2/20 0.58
CYP1A2 P05177 1/20 0.58
CYP3A4 P08684 1/20 0.58
CYP2C9 P11712 1/20 0.58
CYP2C19 P33261 1/20 0.58
MAPK1 P28482 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
TSHR P16473 1/20 0.56
ALOX15 P16050 1/20 0.47
HPGD P15428 2/20 0.44
TP53 P04637 1/20 0.44
ENPP3 O14638 2/20 0.44
ALPL P05186 2/20 0.44
XIAP P98170 2/20 0.44
KDM4E B2RXH2 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32666111 1.00 ASAH1 (0.60) ASAH1ALDH1A1KMT2AMEN1CYP1A2
SCHEMBL24977106 0.94 ASAH1 (0.70) ASAH1ALDH1A1KMT2AMEN1CYP1A2
SCHEMBL19728236 0.94 ASAH1 (0.70) ASAH1ALDH1A1KMT2AMEN1CYP1A2
SCHEMBL32666117 0.91 TSHR (0.56) ASAH1ALDH1A1KMT2AMEN1CYP1A2
SCHEMBL13649525 0.91 ASAH1 (0.53) ASAH1ALDH1A1KMT2AMEN1CYP1A2
SCHEMBL10069783 0.90 ASAH1 (0.52) ASAH1ALDH1A1KMT2AMEN1CYP1A2
SCHEMBL15520980 0.89 ASAH1 (0.51) ASAH1ALDH1A1KMT2AMEN1CYP1A2
SCHEMBL15386147 0.89 ASAH1 (0.51) ASAH1ALDH1A1KMT2AMEN1CYP1A2
SCHEMBL15386851 0.88 ASAH1 (0.50) ASAH1ALDH1A1KMT2AMEN1CYP1A2
SCHEMBL14598862 0.88 ASAH1 (0.50) ASAH1ALDH1A1KMT2AMEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 491 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6423486-B1 None US disclosed
EP-4685138-A1 PROCESS FOR PREPARING PROTECTED AMINES, PYRAZOLOCARBONYL-PROTECTED AMINES AND PEPTIDES Universiteit Antwerpen (BE) 2026-01-28 EP disclosed
US-20230295368-A1 CATALYST FOR DISSOCIATION OF BLOCKING AGENT FOR BLOCKED ISOCYANATES, AND THERMOSETTING COMPOSITION CONTAINING SAID CATALYST FOR DISSOCIATION OF BLOCKING AGENT KOEI CHEMICAL COMPANY, LIMITED (JP) 2023-09-21 US disclosed
US-11718704-B2 Catalyst for dissociation of blocking agent for blocked isocyanates, and thermosetting composition containing said catalyst for dissociation of blocking agent KOEI CHEMICAL COMPANY, LIMITED (JP) 2023-08-08 US disclosed
EP-3689931-A1 CATALYST FOR DISSOCIATION OF BLOCKING AGENT FOR BLOCKED ISOCYANATES, AND THERMOSETTING COMPOSITION CONTAINING SAID CATALYST FOR DISSOCIATION OF BLOCKING AGENT Koei Chemical Company, Limited (JP) 2020-08-05 EP disclosed
US-20200216600-A1 CATALYST FOR DISSOCIATION OF BLOCKING AGENT FOR BLOCKED ISOCYANATES, AND THERMOSETTING COMPOSITION CONTAINING SAID CATALYST FOR DISSOCIATION OF BLOCKING AGENT KOEI CHEMICAL COMPANY, LIMITED (JP) 2020-07-09 US disclosed
WO-2019065953-A1 CATALYST FOR DISSOCIATION OF BLOCKING AGENT FOR BLOCKED ISOCYANATES, AND THERMOSETTING COMPOSITION CONTAINING SAID CATALYST FOR DISSOCIATION OF BLOCKING AGENT 広栄化学工業株式会社 2019-04-04 WO disclosed
US-9761741-B2 Film-forming material NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2017-09-12 US disclosed
US-20130298792-A1 LITHOGRAPHIC PRINTING PLATE PRECURSOR AGFA GRAPHICS NV (BE) 2013-11-14 US disclosed
US-20130284262-A1 FILM-FORMING MATERIAL NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2013-10-31 US disclosed
EP-0533007-A1 Thermally developable photographic elements MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1993-03-24 EP disclosed
US-5196301-A 3-substituted-5-alkylthio-1,2,4-triazoles MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1993-03-23 US disclosed
US-5175081-A Post-processsing stabilization of photothermographic emulsions MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1992-12-29 US disclosed
US-5158866-A POST-PROCESSING STABILIZATION OF PHOTOTHERMOGRAPHIC EMULSIONS WITH AMIDO COMPOUNDS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1992-10-27 US disclosed
US-5149620-A 5-mercapto-1,2,4-triazole derivatives MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1992-09-22 US disclosed
EP-0480568-A2 Post-processing stabilization of photothermographic emulsions MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1992-04-15 EP disclosed
EP-0473351-A2 Post-processing stabilization of photothermographic emulsions with amido compounds MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1992-03-04 EP disclosed
WO-1992002853-A1 POST-PROCESSING STABILIZATION OF PHOTOTHERMOGRAPHIC EMULSIONS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1992-02-20 WO disclosed
US-4923792-A BENZYLIDENE LEUCO COMPOUNDS AS COLOR-GENERATING REDUCING AGENTS, TOPCOAT OF POLYVINYL ALCOHOL MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1990-05-08 US disclosed
US-4883747-A LIGHT SENSITIVE SILVER HALIDE, ORGANIC ACID SILVER SALT, LEUCO DYE MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1989-11-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295368-A1 CATALYST FOR DISSOCIATION OF BLOCKING AGENT FOR BLOCKED ISOCYANATES, AND THERMOSETTING COMPOSITION CONTAINING SAID CATALYST FOR DISSOCIATION OF BLOCKING AGENT IDH3A, RCOR1, MUS81 ASAH1 3473/4885ALDH1A1 1038/4885KMT2A 236/4885
US-11718704-B2 Catalyst for dissociation of blocking agent for blocked isocyanates, and thermosetting composition containing said catalyst for dissociation of blocking agent IDH3A, RCOR1, MUS81 ASAH1 3473/4885ALDH1A1 1038/4885KMT2A 236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.